“If you wait until the last moment, you will have the best chance of designing a vaccine that is best able to tackle the variant that is most widespread but you do not want to risk production failing to deliver sufficient doses,” said Professor Francois Balloux (UCL Biosciences).
Read: Guardian, More: Metro
Close
